KR920021144A - 역류성 식도염을 치료하기위한 니자티딘의 용도 - Google Patents

역류성 식도염을 치료하기위한 니자티딘의 용도 Download PDF

Info

Publication number
KR920021144A
KR920021144A KR1019920008916A KR920008916A KR920021144A KR 920021144 A KR920021144 A KR 920021144A KR 1019920008916 A KR1019920008916 A KR 1019920008916A KR 920008916 A KR920008916 A KR 920008916A KR 920021144 A KR920021144 A KR 920021144A
Authority
KR
South Korea
Prior art keywords
nizatidine
reflux esophagitis
treat reflux
ulcers
dosage regimen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019920008916A
Other languages
English (en)
Korean (ko)
Inventor
루이스 클라우드 미쉘
Original Assignee
리로이 휘테커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리로이 휘테커, 일라이 릴리 앤드 캄파니 filed Critical 리로이 휘테커
Publication of KR920021144A publication Critical patent/KR920021144A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019920008916A 1991-05-28 1992-05-26 역류성 식도염을 치료하기위한 니자티딘의 용도 Withdrawn KR920021144A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70614591A 1991-05-28 1991-05-28
US706,145 1991-05-28

Publications (1)

Publication Number Publication Date
KR920021144A true KR920021144A (ko) 1992-12-18

Family

ID=24836392

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920008916A Withdrawn KR920021144A (ko) 1991-05-28 1992-05-26 역류성 식도염을 치료하기위한 니자티딘의 용도

Country Status (10)

Country Link
EP (1) EP0516345A1 (enExample)
JP (1) JPH05148142A (enExample)
KR (1) KR920021144A (enExample)
AU (1) AU1721892A (enExample)
CA (1) CA2069162A1 (enExample)
HU (1) HU9201751D0 (enExample)
MX (1) MX9202507A (enExample)
NO (1) NO922019L (enExample)
TW (1) TW202387B (enExample)
ZA (1) ZA923711B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ709754A (en) 2004-10-21 2017-02-24 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
PT3354276T (pt) * 2007-11-13 2020-04-06 Meritage Pharma Inc Composições para o tratamento de inflamação gastrointestinal
RU2563623C2 (ru) 2009-12-02 2015-09-20 Апталис Фарма Лимитед Микрокапсулы фексофенадина и содержащие их композиции

Also Published As

Publication number Publication date
NO922019L (no) 1992-11-30
EP0516345A1 (en) 1992-12-02
MX9202507A (es) 1992-11-01
TW202387B (enExample) 1993-03-21
AU1721892A (en) 1992-12-03
NO922019D0 (no) 1992-05-22
CA2069162A1 (en) 1992-11-29
JPH05148142A (ja) 1993-06-15
ZA923711B (en) 1993-11-22
HU9201751D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
KR920019347A (ko) 당뇨병의 치료방법
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
KR890004709A (ko) 항원충제로서의 아지트로마이신 및 이의 유도체
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
KR920000315A (ko) 모다피닐의 용도
KR900701261A (ko) 비만증 치료방법
KR930702007A (ko) 베티-글루쿠로니다제 억제제
KR920021144A (ko) 역류성 식도염을 치료하기위한 니자티딘의 용도
KR900004338A (ko) 5-(4-클로로페닐)-2,4- 디메틸-3h-1,2,4- 트리아졸-3-티온을 이용한 혈소판증가증의 치료방법
KR890700026A (ko) 건선 치료에 있어서 주석 프로토포르피린 및 주석 메조포르피린의 용도
ES2039609T3 (es) Un anestesico.
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
KR890000097A (ko) 항레트로비루스 작용을 갖는 당단백질 처리 억제제
KR920017669A (ko) 갈륨 화합물
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
KR920017668A (ko) 암 전이 억제 또는 예방 방법 및 이를 위한 제제
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
KR940701249A (ko) 진통제
IT1224250B (it) Associzione del depiprazolo con la morfina
FI945446A0 (fi) Kotiinin käyttö tupakan vieroitusoireyhtymän lievittämiseksi

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19920526

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid